Benchmark Holdings (GB:BMK) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Benchmark Holdings is set to undergo a significant business transformation as it seeks shareholder approval for the disposal of its Genetics Business. The move, which constitutes a fundamental change under AIM Rules, is already backed by a majority of shareholders and is expected to be finalized in early 2025. This strategic shift aims to streamline Benchmark’s operations and focus on its core aquaculture biotechnology services.
For further insights into GB:BMK stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- BTCC, WGMI: 2 Bitcoin ETFs for Crypto Exposure
- Shareholder Alert for PACS Group, Inc. (NYSE:PACS)
- Netflix Wins Shareholder Lawsuit Alleging Misleading Growth Forecasts
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
